A team led by Mass General Brigham researchers demonstrated that inebilizumab reduced the risk of symptoms by 87% in patients with the rare affliction known as immunoglobulin G4–related disease (IgG4- ...
Diabetes mellitus is a common, chronic metabolic disease that affects a variety of organs including the skin, the largest organ in the body. Between 30 and 70 percent of people ...